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Background: Disseminated nocardiosis is a relatively rare 
disease that commonly has CNS, pulmonary and 
cutaneous involvement. Medical advancements have led to 
an increase in numbers of chronically immunosuppressed 
patients and a subsequent rise in the incidence of 
disseminated nocardiosis. Nocardiosis should be 
suspected in immunosuppressed patients with pulmonary 
and neurologic or subcutaneous findings. Although it is 
treatable, early diagnosis and initiation of appropriate multi-
agent antibiotic therapy are key for reducing mortality. 
 
Case Description: A 56 year old man with Wegener’s 
Granulomatosis and end-stage renal failure requiring 
hemodialysis had been treated with cyclophosphamide, 
and prednisone for several months, then switched to 
prednisone and rituximab. One week after initiation of 
rituximab, he developed respiratory failure due to acute 
pulmonary edema requiring intubation. During the 
hospitalization, staff noticed two large subcutaneous 
masses. After discharge, he continued with progressive 
physical decline. Two weeks after his 2nd rituximab 
infusion, he developed acute left-sided weakness, ataxia 
and confusion. Plain films revealed a multi-lobar 
pneumonia and CT of the head revealed multiple brain 
lesions. He was transferred to our hospital, where CT 
demonstrated a cavitary lung mass, and MRI demonstrated 
multiple small abscesses. Broad-spectrum antibiotics were 
started. Labs returned with elevated Fungitell®, 
indeterminate Quantiferon®-TB, and negative tests for 
Toxoplasma, Histoplasma and Cryptococcus. Aspirates 
from the subcutaneous masses demonstrated branching 
gram positive rods, later identified as Nocardia farcinica. 
Meropenem, linezolid and amikacin were initially started. 
Trimethoprim-sulfamethoxazole was avoided due to renal 
failure and sulfonamide allergy. Linezolid was later 
switched to minocycline due to thrombocytopenia. 
Abdominal pain prompted the discovery of a large, multi-
loculated pancreatic pseudocyst which grew Candida 
albicans. His condition continued to decline despite 
appropriate therapy, and he was discharged to home with 
hospice.  
Discussion:  Although this case was complicated by 
multiple co-morbidities, it illustrates the importance of 
considering Nocardiosis in the immunosuppressed patient 
with pulmonary and neurologic or subcutaneous findings. 
Commonly used serologic laboratory tests are not useful in 
diagnosis, which requires a sample of the involved tissue to 
be sent for culture. Treatment of Nocardia species requires 
long-term antibiotic therapy. Nocardia farcinica is generally 
more antibiotic resistant than other species and possibly 
more virulent. The mainstay of treatment is generally 
trimethoprim-sulfamethoxazole for susceptible species, with 
empiric combinations generally involving amikacin and 
imipenem until susceptibilities return. In this patient, renal 
failure and sulfonamide intolerance further complicated 
treatment.  
Non-contrast MRI image demonstrating multiple small abscesses.  
 
 
 
 
Non-contrast CT image demonstrating infiltrates and cavitary lesion. 
Gram stain (above) of Nocardia demonstrating a typical poorly-staining beaded, 
branching gram positive rod. Photo courtesy of Marsha Wilson, MT. 
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